News
Follow Gallant’s latest news, announcements, and conversations shaping the future of veterinary regenerative medicine.
Gallant in the News
News Releases
Interviews
Gallant in the News
Los Angeles Times: Clinical Data on Mesenchymal Stromal Cell Efficacy from Gallant
Read more
Fountain Report: Regenerative Therapy Q&A with Dr. Linda Black
Read more
DVM360: Busting myths around stem cell therapy
Read more
TechCrunch Spotlights Gallant’s Breakthrough Approach to Stem Cell Therapy in Veterinary Medicine
Read more
dvm360 Reports on Gallant’s Platform and Path Toward FDA-Labeled Therapies
Read more
BioProcess Insider Covers Gallant’s $18M Raise and Manufacturing Expansion
Read more
PetVet Magazine Publishes Feature by Dr. Linda Black on the Rise of Ready-to-Use Stem Cell Therapies
Read more
Veterinary Practice’s Innovation Feature for February 2024 Covers FCGS Study
Read more
News Releases
Gallant Advances Canine Osteoarthritis IV-Delivered MSC Therapy with Promising Pilot Data and Expanded FDA Conditional Approval Pathway Eligibility
Read more
Gallant Reports Positive Pilot Data for Feline Osteoarthritis MSC Therapy; Receives FDA Eligibility for Expanded Conditional Approval Pathway
Read more
National Survey: Veterinary Professionals See Stem Cell Therapy as a Powerful New Tool for Inflammatory Diseases in Pets
Read more
Gallant Announces First-of-Its-Kind Partnership with MWI Animal Health to Deliver Anticipated FDA-Conditionally Approved MSC Therapy into Veterinary Clinics
Read more
FDA Completes Safety for Gallant’s First Ready-to-Use MSC Therapy for Refractory FCGS
Read more
Biotech and Veterinary Innovators Dr. Misti Ushio and Doug Drew Join Gallant Board of Directors
Read more
Gallant Achieves FDA “Technical Section Complete” for Reasonable Expectation of Effectiveness, Advancing First Ready-to-Use MSC Therapy
Read more
Gallant Debuts GallantU: A Comprehensive CE Platform Preparing Veterinary Professionals for the Regenerative Medicine Era
Read more
Gallant Closes $18 Million Series B to Bring Ready-to-Use Stem Cell Therapies for Pets to Market
Read more
Gallant Names Dr. Rebecca Windsor Director of Veterinary Affairs as Company Advances Its Off-the-Shelf Stem Cell Therapy for Cats
Read more
Gallant Therapeutics Raises Over $15 Million in Series A Funding to Advance Pipeline of “Off-the-Shelf” Stem Cell Therapies for Pets
Read more
View more posts in this category
View All
Interviews
Restoring Health at the Source: Dr. Linda Black on the Future of Regenerative Veterinary Care
Read more
Dr. Rebecca Windsor on MSC Therapy Advances in FCGS
Read more
From Neurology to Regenerative Medicine: Dr. Rebecca Windsor on Vet Life Reimagined
Read more
Why Stem Cells Could Replace Expensive Pet Meds: Dr. Linda Black in The Woof
Read more
A New Era of Veterinary Care: Dr. Linda Black on The Veterinary Roundtable
Read more
Dr. Linda Black on Fountain Report: Stem Cells, FDA Pathways, and the Future of Veterinary Medicine
Read more
Gallant CEO Dr. Linda Black Joins The Bird Bath to Discuss $18M Series B and the Future of Regenerative Medicine
Read more
The People of Animal Health: Episode #41 – Dr. Linda Black
Read more
Veterinary Innovation Podcast: ‘Off-the-Shelf’ Stem Cell Therapies in Veterinary Care
Read more
VETgirl: Should I Pursue Research in Veterinary Medicine with Dr. Linda Black
Read more
My Veterinary Life: From Colics to Cures: Dr. Linda Black’s Mission to Transform Veterinary Medicine
Read more
View more posts in this category
View All
